查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1961337

血小板凝集装置市场 - 全球产业规模、份额、趋势、机会、预测：按产品类型、应用、最终用户、地区和竞争对手划分，2021-2031年

Platelet Aggregation Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球血小板凝集装置市场预计将从 2025 年的 9.2268 亿美元成长到 2031 年的 12.5211 亿美元，复合年增长率为 5.22%。

这些专用诊断设备旨在评估血小板聚集和形成血栓的能力，在评估止血功能和确定抗血小板治疗效果方面发挥着至关重要的作用。推动市场成长的关键因素包括全球心血管疾病发生率的上升，以及由此导致的临床和外科手术中对严格血小板功能检查需求的增加。此外，人口老化使得定期监测血栓风险成为必要，从而维持了对这些诊断系统的稳定需求。根据英国心臟基金会的数据，2023年心血管和循环系统疾病约占全球所有死亡人数的三分之一。

市场概览
预测期 2027-2031
市场规模：2025年 9.2268亿美元
市场规模：2031年 1,252,110,000 美元
复合年增长率：2026-2031年 5.22%
成长最快的细分市场 耗材和配件
最大的市场 北美洲

然而，限制该市场更广泛扩张的一大挑战是先进的自动化凝集检测系统及其维护成本高成本。这些经济负担构成了一大障碍，尤其对于发展中地区的小规模诊所和医疗机构而言，使得投资此类专用设备变得困难。因此，这些经济限制阻碍了市场渗透，并限制了资源匮乏地区快速血小板功能检查的普及。

市场驱动因素

慢性病和心血管疾病的日益普遍是推动血小板凝集分析仪普及应用的主要动力。随着中风和冠状动脉疾病等疾病在全球范围内负担加重，临床检查室正将严格的血小板功能检查作为优先事项，旨在更好地管理抗血小板治疗并最大限度地降低血栓风险。这对于接受介入治疗的患者尤其重要，因为监测止血功能对于预防出血和支架血栓症等不利事件至关重要。根据美国心臟协会于2024年1月发布的《2024年心臟病和中风统计数据》，约48.6%的美国成年人患有某种形式的心血管疾病，凸显了对这一大规模患者群体进行有效诊断监测的紧迫性。

同时，老年人口的快速成长是市场需求的主要驱动力。这是因为老年人更容易罹患血小板相关疾病，且通常需要长期服药。在高龄化社会中，频繁的诊断筛检对于调整治疗方案和确保复杂手术期间的病人安全至关重要。根据世界卫生组织（世卫组织）于2024年5月发布的《2024年世界卫生统计》，全球60岁以上人口预计将从2023年的11亿增加到2030年的14亿。为因应人口结构变化带来的介入技术需求，领先的医疗科技公司正呈现强劲成长动能。雅培公司在2024年10月公布，第三季全球医疗设备销售额成长了11.7%。

市场挑战

先进的自动化血小板聚集检测系统的实施和维护成本高昂，是限制全球血小板凝集检测市场成长的主要障碍。这些设备需要大量的初始投资，因此难以推广应用，尤其对于预算有限的发展中地区的小规模诊所和医疗机构而言更是如此。除了购置成本外，校准、专用试剂和技术服务等持续性费用也进一步加重了诊断中心的营运负担。因此，经济负担限制了现代血小板功能检查的应用，使其仅限于资金雄厚的大型医院，导致相当一部分潜在市场尚未开发。

诊断服务提供者日益恶化的财务环境进一步加剧了这种经济压力。据美国诊断和临床实验室医师协会 (ADLM) 称，拟议削减高达 15% 的联邦医疗保险 (Medicare) 对关键诊断测试的支付，将为临床检查室在 2024 年带来巨大的财务不确定性。此类报销限制严重限制了可用于基础设施升级的资金。因此，医疗机构不太可能投资昂贵的自动化系统，这直接阻碍了这些关键诊断设备的市场渗透。

市场趋势

随着医疗机构努力解决人员短缺问题并应对日益增长的检测量，向自动化、高通量检测系统的转变正在重塑全球血小板凝集)分析仪市场。检查室正逐步摒弃劳力密集的手动光透射凝集检测法，转而采用整合式止血工作站，从而简化检体处理和数据管理。这种转变不仅提高了工作流程效率，还实现了大规模医疗网路内检测结果的标准化，减少了传统方法中固有的操作者差异。市场领导的财务表现也印证了对扩充性自动化解决方案的需求。根据 Warfen 于 2025 年 3 月发布的《2024 年年度报告》，其止血部门在 2024 年实现了 6.6% 的收入成长，这主要得益于专业自动化和资料管理解决方案的应用。

同时，机器学习 (ML) 和人工智慧 (AI) 的融合正在革新对复杂血小板功能数据的解读。製造商正将 AI 演算法整合到诊断软体中，以更精确地分析血小板聚集曲线，从而能够早期发现可能预示血栓风险或对抗血小板治疗无反应的异常情况。这些先进的分析工具透过提供预测性见解来支持临床决策，并有助于为心血管疾病患者制定更个人化的治疗策略。支持这项技术的监管环境也在快速发展。根据《医疗未来学家》(The Medical Futurist) 于 2025 年 7 月发布的关于 FDA核准的AI医疗设备的报告，仅在 2025 年上半年，FDA 就批准了 148 种新的 AI 设备，这表明智慧诊断技术的部署正在加速推进。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球血小板凝集装置市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品类型（系统/设备、耗材/配件）
    • 依用途（临床用途、外包）
    • 依最终使用者（医院、诊断中心、研究机构、学术机构）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美血小板凝集装置市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲血小板凝集仪市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区血小板凝集装置的市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲血小板凝集装置的市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲血小板凝集装置的市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球血小板凝集装置市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • AggreDyne, Inc.
  • Bio/Data Corporation
  • Chrono-Log Corporation
  • F. Hoffmann-La Roche Ltd.
  • Haemonetics Corporation
  • Siemens Healthineers AG
  • Werfen, SA
  • Sysmex Corporation
  • Sienco, Inc.
  • Drucker Diagnostics

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 24017

The Global Platelet Aggregation Devices Market is projected to expand from USD 922.68 Million in 2025 to USD 1252.11 Million by 2031, registering a CAGR of 5.22%. These specialized diagnostic instruments are designed to assess the ability of thrombocytes to cluster and form clots, which is fundamental for evaluating hemostasis and determining the effectiveness of antiplatelet therapies. Key drivers fueling this market growth include the rising global incidence of cardiovascular conditions and the subsequent need for rigorous platelet function testing in both clinical and surgical settings. Furthermore, the expanding geriatric population necessitates regular monitoring for thrombotic risks, thereby maintaining a steady demand for these diagnostic systems. Data from the British Heart Foundation indicates that in 2023, circulatory and cardiovascular diseases were responsible for approximately one-third of all global deaths.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 922.68 Million
Market Size 2031USD 1252.11 Million
CAGR 2026-20315.22%
Fastest Growing SegmentConsumables & Accessories
Largest MarketNorth America

However, a significant challenge limiting the broader expansion of this market is the high cost linked to advanced automated aggregometry systems and their required maintenance. These financial demands pose a barrier for smaller clinics and healthcare facilities, particularly in developing regions, making it difficult to invest in such specialized equipment. Consequently, these economic constraints hinder market penetration and restrict the availability of rapid platelet function testing in resource-limited environments.

Market Driver

The increasing prevalence of chronic and cardiovascular diseases serves as a primary catalyst for the adoption of platelet aggregation devices. As the global burden of conditions such as stroke and coronary artery disease grows, clinical laboratories are prioritizing rigorous platelet function testing to manage antiplatelet therapies and minimize thrombotic risks. This is especially critical for patients undergoing interventional procedures, where monitoring hemostasis is vital to prevent adverse events like bleeding or stent thrombosis. According to the American Heart Association's "Heart Disease and Stroke Statistics-2024 Update" from January 2024, approximately 48.6% of adults in the United States have some form of cardiovascular disease, highlighting the urgent need for effective diagnostic monitoring for this large patient population.

Simultaneously, the rapid expansion of the geriatric population significantly drives market demand, as elderly individuals are more susceptible to platelet-related disorders and often require chronic medication management. An aging demographic necessitates frequent diagnostic screenings to adjust therapeutic regimens and ensure patient safety during complex surgeries. According to the World Health Organization's "World Health Statistics 2024" released in May 2024, the global population aged 60 years and older is expected to rise from 1.1 billion in 2023 to 1.4 billion by 2030. Reflecting the demand for interventional technologies driven by these demographic shifts, major medtech companies are seeing strong growth; Abbott Laboratories reported in October 2024 that global medical device sales increased by 11.7% on a reported basis in the third quarter.

Market Challenge

The substantial cost associated with acquiring and maintaining advanced automated aggregometry systems represents a major obstacle to the growth of the Global Platelet Aggregation Devices Market. These instruments require a significant initial capital investment, which is often prohibitive for smaller clinics and healthcare facilities, particularly in developing regions with limited budgets. Beyond the purchase price, recurring expenses for calibration, specialized reagents, and technical servicing further strain the operational finances of diagnostic centers. As a result, the financial burden limits the adoption of modern platelet function testing primarily to large, well-funded hospitals, leaving a significant portion of the potential market untapped.

This economic pressure is exacerbated by a tightening financial landscape for diagnostic providers. According to the Association for Diagnostics & Laboratory Medicine, clinical laboratories faced significant fiscal uncertainty in 2024 due to proposed Medicare payment reductions of up to 15% for key diagnostic tests. Such constraints on reimbursement rates severely limit the capital available for infrastructure upgrades. Consequently, facilities are less likely to invest in expensive automated systems, which directly hampers the broader market penetration of these critical diagnostic devices.

Market Trends

The shift toward automated high-throughput laboratory systems is reshaping the Global Platelet Aggregation Devices Market as facilities aim to address staffing shortages and handle increasing testing volumes. Laboratories are moving away from manual, labor-intensive light transmission aggregometry in favor of integrated hemostasis workcells that streamline sample processing and data management. This transition not only improves workflow efficiency but also standardizes results across large healthcare networks, reducing the inter-operator variability common in traditional methods. The demand for scalable, automated solutions is evident in the financial performance of market leaders; Werfen's "Annual Review 2024," published in March 2025, noted that its Hemostasis division achieved 6.6% revenue growth in 2024, driven significantly by the adoption of its specialized automation and data management solutions.

Concurrently, the integration of Machine Learning (ML) and Artificial Intelligence (AI) is revolutionizing the interpretation of complex platelet function data. Manufacturers are embedding AI algorithms into diagnostic software to analyze aggregation curves with greater precision, allowing for the early detection of anomalies that may indicate thrombotic risks or non-responsiveness to antiplatelet therapy. These advanced analytics tools support clinical decision-making by providing predictive insights, facilitating more personalized treatment strategies for cardiovascular patients. The regulatory landscape is rapidly evolving to support this technology; according to a July 2025 report by The Medical Futurist on FDA-approved AI-based medical devices, the FDA authorized 148 new AI-enabled devices in the first half of 2025 alone, signaling a robust acceleration in the deployment of intelligent diagnostic technologies.

Key Market Players

  • AggreDyne, Inc.
  • Bio/Data Corporation
  • Chrono-Log Corporation
  • F. Hoffmann-La Roche Ltd.
  • Haemonetics Corporation
  • Siemens Healthineers AG
  • Werfen, S.A.
  • Sysmex Corporation
  • Sienco, Inc.
  • Drucker Diagnostics

Report Scope

In this report, the Global Platelet Aggregation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Platelet Aggregation Devices Market, By Product Type

  • Systems & Instruments
  • Consumables & Accessories

Platelet Aggregation Devices Market, By Application

  • Clinical Applications
  • Outsourced

Platelet Aggregation Devices Market, By End User

  • Hospital
  • Diagnostic Centers
  • Research
  • Academic Institutes

Platelet Aggregation Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Platelet Aggregation Devices Market.

Available Customizations:

Global Platelet Aggregation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Platelet Aggregation Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Systems & Instruments, Consumables & Accessories)
    • 5.2.2. By Application (Clinical Applications, Outsourced)
    • 5.2.3. By End User (Hospital, Diagnostic Centers, Research, Academic Institutes)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Platelet Aggregation Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Platelet Aggregation Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Platelet Aggregation Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Platelet Aggregation Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Platelet Aggregation Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Platelet Aggregation Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. France Platelet Aggregation Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Platelet Aggregation Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Platelet Aggregation Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Platelet Aggregation Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia Pacific Platelet Aggregation Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Platelet Aggregation Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Platelet Aggregation Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Platelet Aggregation Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Platelet Aggregation Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Platelet Aggregation Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. Middle East & Africa Platelet Aggregation Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Platelet Aggregation Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Platelet Aggregation Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Platelet Aggregation Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. South America Platelet Aggregation Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Platelet Aggregation Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Platelet Aggregation Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Platelet Aggregation Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Platelet Aggregation Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. AggreDyne, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Bio/Data Corporation
  • 15.3. Chrono-Log Corporation
  • 15.4. F. Hoffmann-La Roche Ltd.
  • 15.5. Haemonetics Corporation
  • 15.6. Siemens Healthineers AG
  • 15.7. Werfen, S.A.
  • 15.8. Sysmex Corporation
  • 15.9. Sienco, Inc.
  • 15.10. Drucker Diagnostics

16. Strategic Recommendations

17. About Us & Disclaimer